Radiotherapy and combination chemotherapy in advanced Ewing's Sarcoma-Intergroup study

Area of Science:

• Pediatric Oncology
• Medical Oncology
• Sarcoma Research

Background:

• Ewing's sarcoma is a rare bone and soft tissue cancer primarily affecting children and young adults.
• Metastatic and advanced regional Ewing's sarcoma present significant treatment challenges with historically poor prognoses.
• The need for effective multimodal treatment strategies is critical for improving patient outcomes.

Purpose of the Study:

• To evaluate the efficacy of an intensive combination chemotherapy and radiotherapy protocol in patients with metastatic or advanced regional Ewing's sarcoma.
• To assess the rates of complete remission, partial remission, and treatment response.
• To determine the duration of disease-free survival and identify factors influencing recurrence.

Main Methods:

• A cohort of 44 patients with metastatic (36) and advanced regional (8) Ewing's sarcoma was treated.
• The treatment protocol involved intensive combination chemotherapy and radiotherapy directed at all sites of overt disease.
• Patient responses, remission status, disease-free survival, and treatment-related complications were meticulously monitored.

Main Results:

• Thirty-one patients achieved a complete remission (CR), eight achieved a partial remission (PR), and five showed no response.
• Among the 31 patients in CR (12 metastatic, 6 regional), 18 remained disease-free at a median follow-up of 34 months.
• Nine patients experienced recurrence, and four died due to treatment complications.

Conclusions:

• Intensive multimodal management, combining chemotherapy and radiotherapy, can achieve prolonged disease-free survival in metastatic Ewing's sarcoma.
• This aggressive treatment approach offers the potential for cure in a significant percentage of patients with advanced disease.
• While late relapses are possible, the study highlights the promise of intensive therapy for improving outcomes in Ewing's sarcoma.